Idexx Laboratories
IDXX
1,032 hedge funds and large institutions have $39.7B invested in Idexx Laboratories in 2022 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 364 increasing their positions, 409 reducing their positions, and 142 closing their positions.
1.83% more ownership
Funds ownership: 84.62% → 86.45% (+1.8%)
7% less funds holding
Funds holding: 1,107 → 1,032 (-75)
11% less repeat investments, than reductions
Existing positions increased: 364 | Existing positions reduced: 409
15% less funds holding in top 10
Funds holding in top 10: 33 → 28 (-5)
16% less capital invested
Capital invested by funds: $47.1B → $39.7B (-$7.3B)
37% less call options, than puts
Call options by funds: $111M | Put options by funds: $177M
46% less first-time investments, than exits
New positions opened: 77 | Existing positions closed: 142
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIS
Fundsmith Investment Services
Grande Riviere Noire,
Mauritius
|
+$501M |
| 2 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$240M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$195M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$182M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$181M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fundsmith LLP
London,
United Kingdom
|
-$328M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$211M |
| 3 |
Bank of New York Mellon
New York
|
-$98M |
| 4 |
Amundi
Paris,
France
|
-$76.5M |
| 5 |
Morgan Stanley
New York
|
-$66.8M |
IDXX Hedge Fund Activity: Q1 2022 in Review
1,032 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q1 2022, worth a combined $39.7B — down 16% from $47.1B a quarter earlier.
Sellers outnumbered buyers: 142 funds closed out of IDXX and 77 opened new positions — a net loss of 65 holders — while 409 trimmed existing stakes and 364 added.
The largest buyer was Fundsmith Investment Services, opening a new position worth an estimated $501M. The largest seller was Fundsmith LLP, cutting an estimated $328M.
- 1,032 institutional investors held Idexx Laboratories (IDXX) as of Q1 2022, down from 1,107 in Q4 2021.
- Funds reported $39.7B of Idexx Laboratories stock for Q1 2022, down 16% quarter-over-quarter.
- 77 funds opened new Idexx Laboratories positions in Q1 2022 and 142 closed out, a net change of -65 holders.
- The largest Idexx Laboratories buyer in Q1 2022 was Fundsmith Investment Services, an estimated $501M added.
- The largest Idexx Laboratories seller in Q1 2022 was Fundsmith LLP, an estimated $328M sold.
Based on aggregated 13F filings for Q1 2022.